(Q38341518)

English

Beneficial effect of berberine on hepatic insulin resistance in diabetic hamsters possibly involves in SREBPs, LXR.ALPHA. and PPAR.ALPHA. transcriptional programs

scientific article published on August 17, 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Beneficial effect of berberine on hepatic insulin resistance in diabetic hamsters possibly involves in SREBPs, LXRα and PPARα transcriptional programs (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Beneficial effect of berberine on hepatic insulin resistance in diabetic hamsters possibly involves in SREBPs, LXR.ALPHA. and PPAR.ALPHA. transcriptional programs (English)

1 reference

10.1507/ENDOCRJ.K10E-043

https://api.crossref.org/works/10.1507/ENDOCRJ.K10E-043

20 June 2024

insulin resistance

1 reference

based on heuristic

inferred from title

author name string

Xuhan Liu

1

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Guosheng Li

2

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Hua Zhu

3

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Lan Huang

4

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Yali Liu

5

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Chunmei Ma

6

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Chuan Qin

7

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20724798

20 June 2024

publication date

17 August 2010

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Endocrine Journal

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

57

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

881-893

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Transcript profiling suggests that differential metabolic adaptation of mice to a high fat diet is associated with changes in liver to muscle lipid fluxes

1

1 reference

10.1507/ENDOCRJ.K10E-043

https://api.crossref.org/works/10.1507/ENDOCRJ.K10E-043

20 June 2024

Effects of pine needle extract on differentiation of 3T3-L1 preadipocytes and obesity in high-fat diet fed rats

2

1 reference

10.1507/ENDOCRJ.K10E-043

https://api.crossref.org/works/10.1507/ENDOCRJ.K10E-043

20 June 2024

Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes

4

1 reference

10.1507/ENDOCRJ.K10E-043

https://api.crossref.org/works/10.1507/ENDOCRJ.K10E-043

20 June 2024

Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice

5

1 reference

10.1507/ENDOCRJ.K10E-043

https://api.crossref.org/works/10.1507/ENDOCRJ.K10E-043

20 June 2024

Antiproliferative activity of berberine in vitro and in vivo

7

1 reference

10.1507/ENDOCRJ.K10E-043

https://api.crossref.org/works/10.1507/ENDOCRJ.K10E-043

20 June 2024

Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states

10

1 reference

10.1507/ENDOCRJ.K10E-043

https://api.crossref.org/works/10.1507/ENDOCRJ.K10E-043

20 June 2024

Nongenetic mouse models of non-insulin-dependent diabetes mellitus.

12

1 reference

10.1507/ENDOCRJ.K10E-043

https://api.crossref.org/works/10.1507/ENDOCRJ.K10E-043

20 June 2024

Kidney involvement in a nongenetic rat model of type 2 diabetes

13

1 reference

10.1507/ENDOCRJ.K10E-043

https://api.crossref.org/works/10.1507/ENDOCRJ.K10E-043

20 June 2024

Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic beta-cell mass and function in a rodent model of type 2 diabetes.

14

1 reference

10.1507/ENDOCRJ.K10E-043

https://api.crossref.org/works/10.1507/ENDOCRJ.K10E-043

20 June 2024

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

15

1 reference

10.1507/ENDOCRJ.K10E-043

https://api.crossref.org/works/10.1507/ENDOCRJ.K10E-043

20 June 2024

Effects of berberine on glucose metabolism in vitro

17

1 reference

10.1507/ENDOCRJ.K10E-043

https://api.crossref.org/works/10.1507/ENDOCRJ.K10E-043

20 June 2024

Metabolic Impact of Adenovirus-mediated Overexpression of the Glucose-6-phosphatase Catalytic Subunit in Hepatocytes

18

1 reference

10.1507/ENDOCRJ.K10E-043

https://api.crossref.org/works/10.1507/ENDOCRJ.K10E-043

20 June 2024

Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver.

19

1 reference

10.1507/ENDOCRJ.K10E-043

https://api.crossref.org/works/10.1507/ENDOCRJ.K10E-043

20 June 2024

Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lep(ob)/Lep(ob) mice

21

1 reference

10.1507/ENDOCRJ.K10E-043

https://api.crossref.org/works/10.1507/ENDOCRJ.K10E-043

20 June 2024

SREBPs suppress IRS-2-mediated insulin signalling in the liver

22

1 reference

10.1507/ENDOCRJ.K10E-043

https://api.crossref.org/works/10.1507/ENDOCRJ.K10E-043

20 June 2024

Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system

23

1 reference

10.1507/ENDOCRJ.K10E-043

https://api.crossref.org/works/10.1507/ENDOCRJ.K10E-043

20 June 2024

A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury.

24

1 reference

10.1507/ENDOCRJ.K10E-043

https://api.crossref.org/works/10.1507/ENDOCRJ.K10E-043

20 June 2024

Expression of the peroxisome proliferator-activated receptor gene is decreased in experimental alcoholic liver disease

25

1 reference

10.1507/ENDOCRJ.K10E-043

https://api.crossref.org/works/10.1507/ENDOCRJ.K10E-043

20 June 2024

Administration of the potent PPARalpha agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice

26

1 reference

10.1507/ENDOCRJ.K10E-043

https://api.crossref.org/works/10.1507/ENDOCRJ.K10E-043

20 June 2024

Reduced expression of peroxisome proliferator-activated receptor-alpha may have an important role in the development of non-alcoholic fatty liver disease.

27

1 reference

10.1507/ENDOCRJ.K10E-043

https://api.crossref.org/works/10.1507/ENDOCRJ.K10E-043

20 June 2024

Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity

28

1 reference

10.1507/ENDOCRJ.K10E-043

https://api.crossref.org/works/10.1507/ENDOCRJ.K10E-043

20 June 2024

Identifiers

10.1507/ENDOCRJ.K10E-043

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38341518&oldid=2184093918"